Back to School: How biopharma can reboot drug development. Access exclusive analysis here

U.S. Senate passes reimportation bills

The U.S. Senate voted 69-30 on Wednesday to allow reimportation of FDA-approved drugs from Canada. The Senate also voted 99-0 in a separate vote

Read the full 248 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE